Jorge Luis Trujillo-Ochoa PhD. (@luistrujillophd) 's Twitter Profile
Jorge Luis Trujillo-Ochoa PhD.

@luistrujillophd

Postdoctoral Fellow at the Immunoregulation Section NIDDK NIH l #Immunology l #Tcells l

ID: 1658429101944762369

calendar_today16-05-2023 11:08:43

6 Tweet

8 Followers

55 Following

Immune Regulation News (@immune_news) 's Twitter Profile Photo

πŸ’­ What made you who you are? Authors Jorge Luis Trujillo-Ochoa PhD., Majid Kazemian & @AfzaliBehdad review this question for #Tregs, specifically focusing on the emerging roles of accessory #TranscriptionFactors in shaping #Treg cell identity. Nature Rev Immunol: πŸ“š go.nature.com/44bFn8w

πŸ’­ What made you who you are? 

Authors <a href="/LuisTrujilloPhD/">Jorge Luis Trujillo-Ochoa PhD.</a>, <a href="/kazemianlab/">Majid Kazemian</a> &amp; @AfzaliBehdad review this question for #Tregs, specifically focusing on the emerging roles of accessory #TranscriptionFactors in shaping #Treg cell identity. 
 
<a href="/NatRevImmunol/">Nature Rev Immunol</a>: 
πŸ“š go.nature.com/44bFn8w
Immune Regulation News (@immune_news) 's Twitter Profile Photo

🦘 Jumping into 3rd place in our Top Posts of 2023 is this review by Jorge Luis Trujillo-Ochoa PhD., Majid Kazemian & @AfzaliBehdad β€” a must read for all the #Treg fans! Great work by all the authors! πŸ‘ x.com/Immune_News/st…

Jorge Luis Trujillo-Ochoa PhD. (@luistrujillophd) 's Twitter Profile Photo

New tools for pathways analysis from our team at #NIDDK-NIH and #PU Unbiased discovery of cancer pathways and therapeutics using Pathway Ensemble Tool and Benchmark | Nature Communications nature.com/articles/s4146…

Journal of Clinical Investigation (@jclinicalinvest) 's Twitter Profile Photo

Elevations in local complement are linked with kidney fibrosis that progressively impairs renal function. Portilla et al. highlight the potential for complement-targeted therapeutics to slow fibrosis progression in CKD and other kidney diseases. jci.org/articles/view/…

Elevations in local complement are linked with kidney fibrosis that progressively impairs renal function. 
Portilla et al. highlight the potential for complement-targeted therapeutics to slow fibrosis progression in CKD and other kidney diseases. jci.org/articles/view/…